AI assistant
KLA CORP — Director's Dealing 2012
Feb 17, 2012
29827_dirs_2012-02-17_27fb2c26-7073-4d00-844d-e3c2a12602cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KLA TENCOR CORP (KLAC)
CIK: 0000319201
Period of Report: 2012-02-16
Reporting Person: KAUFMAN STEPHEN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-16 | Common Stock | M | 10000 | $37.05 | Acquired | 26224 | Indirect |
| 2012-02-16 | Common Stock | S | 10000 | $50.5868 | Disposed | 16224 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-16 | Non-Qualified Stock Option (Right to Buy) | $37.05 | M | 5000 | Disposed | 2012-11-08 | Common Stock (5000) | Direct |
| 2012-02-16 | Non-Qualified Stock Option (Right to Buy) | $37.05 | M | 5000 | Disposed | 2012-11-08 | Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock - Restricted Stock Units | 2539 | Direct |
Footnotes
F1: By the Stephen P. Kaufman Trust UAD 5/24/2002, of which the Reporting Person is the trustee.
F2: This transaction was executed in multiple trades at prices ranging from $50.285 to $50.80. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of KLA-Tencor common stock.
F4: Represents one of two stock options granted on November 8, 2002, each granting the Reporting Person the right to purchase up to 5,000 shares of KLA-Tencor common stock. Each such option was immediately exercisable for all of the underlying shares on the date of grant.